We are live on ! Find out more
ICM

Islay Capital Management Portfolio holdings

AUM $197M
1-Year Est. Return 19.56%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+19.56%
3 Year Est. Return
+65.19%
5 Year Est. Return
+82.58%
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$2.36M
Cap. Flow
-$4.08M
Cap. Flow %
-3.3%
Top 10 Hldgs %
43.44%
Holding
324
New
50
Increased
34
Reduced
80
Closed
42

Top Buys

Rank Stock Value
1
RSPT icon
Invesco S&P 500 Equal Weight Technology ETF
RSPT
+$1.95M
2
JNJ icon
Johnson & Johnson
JNJ
+$705K
3
ONEQ icon
Fidelity Nasdaq Composite Index ETF
ONEQ
+$619K
4
IFLN
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
+$376K
5
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$240K

Top Sells

Rank Stock Value
1
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$1.83M
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$1.15M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$1.03M
4
HTLF
Heartland Financial USA, Inc.
HTLF
+$791K
5
SPSM icon
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
+$621K

Sector Composition

Rank Sector Weight
1 Technology 7.81%
2 Financials 6.06%
3 Healthcare 4.69%
4 Consumer Discretionary 3.68%
5 Consumer Staples 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMP
201
DELISTED
Magellan Midstream Partners, L.P.
MMP
$44K 0.04%
900
– –
QCOM icon
202
Qualcomm
QCOM
$155B
$43K 0.03%
300
-771
-72% -$104K
USIG icon
203
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$41K 0.03%
674
– –
MGI
204
DELISTED
MoneyGram International, Inc. New
MGI
$40K 0.03%
4,000
– –
ABBV icon
205
AbbVie
ABBV
$443B
$39K 0.03%
350
– –
ARKK icon
206
ARK Innovation ETF
ARKK
$5.84B
$39K 0.03%
300
– –
IHE icon
207
iShares US Pharmaceuticals ETF
IHE
$1.61B
$39K 0.03%
630
– –
IDXX icon
208
Idexx Laboratories
IDXX
$44.1B
$38K 0.03%
60
– –
ACN icon
209
Accenture
ACN
$102B
$37K 0.03%
125
– –
IBM icon
210
IBM
IBM
$211B
$33K 0.03%
235
– –
ADP icon
211
Automatic Data Processing
ADP
$106B
$32K 0.03%
163
– –
ENB icon
212
Enbridge
ENB
$119B
$31K 0.03%
777
– –
ORCL icon
213
Oracle
ORCL
$374B
$31K 0.03%
400
– –
PFF icon
214
iShares Preferred and Income Securities ETF
PFF
$13.3B
$31K 0.03%
800
– –
CBOE icon
215
Cboe Global Markets
CBOE
$32.5B
$30K 0.02%
250
– –
MU icon
216
Micron Technology
MU
$930B
$30K 0.02%
350
– –
MDY icon
217
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$29K 0.02%
60
– –
PYPL icon
218
PayPal
PYPL
$48.9B
$29K 0.02%
100
-50
-33% -$13.2K
MS icon
219
Morgan Stanley
MS
$331B
$28K 0.02%
300
– –
SCHZ icon
220
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$28K 0.02%
1,008
– –
LULU icon
221
lululemon athletica
LULU
$13.5B
$27K 0.02%
75
– –
MDT icon
222
Medtronic
MDT
$109B
$25K 0.02%
200
– –
KRE icon
223
State Street SPDR S&P Regional Banking ETF
KRE
$4.69B
$23K 0.02%
350
– –
VALE icon
224
Vale
VALE
$64.1B
$23K 0.02%
1,000
– –
BKLN icon
225
Invesco Senior Loan ETF
BKLN
$6.78B
$22K 0.02%
+1,000
New +$22.2K
7 8
9
10 11

Similar funds

RC
RLH Capital Great Neck, New York $197M AUM
SFG
Socha Financial Group Corning, New York $197M AUM 21.75% 1-Year Est. Return
ECP
Elwood Capital Partners New York $197M AUM 13.45% 1-Year Est. Return
GL
Gildi lifeyrissjodur Reykjavik $197M AUM
IMC
Inherent Management Corp New York $197M AUM 23.09% 1-Year Est. Return
OCM
Ogborne Capital Management San Francisco, California $197M AUM 17.33% 1-Year Est. Return
SWM
Steelhead Wealth Management Glen Allen, Virginia $197M AUM
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Islay Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Islay Capital Management held 324 positions worth $124M, up 1.9% from $121M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Islay Capital Management withdrew a net $4.08M in Q2 2021, closing 42 positions and reducing 80 holdings. Its most notable exit was Humana, an estimated $273K position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 6.8% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Islay Capital Management opened a new position in Apellis Pharmaceuticals worth $167K.

  • Islay Capital Management's largest Q2 2021 buy was Apellis Pharmaceuticals: 2,648 shares worth $167K.
  • Islay Capital Management added most to Invesco S&P 500 Equal Weight Technology ETF in Q2 2021, an estimated $1.95M increase.
  • Islay Capital Management's biggest Q2 2021 reduction was Schwab US Dividend Equity ETF, cutting an estimated $1.83M.
  • Islay Capital Management fully exited Humana in Q2 2021, selling an estimated $273K.
  • Islay Capital Management's ten largest holdings make up 43% of its $124M portfolio in Q2 2021.
  • Islay Capital Management opened 50 new positions and closed 42 in Q2 2021.
  • Islay Capital Management's portfolio value rose 1.9% quarter-over-quarter to $124M.

Based on Islay Capital Management's 13F filing for Q2 2021, filed 2 Aug 2021.